m,
oppies ate .02 to pay in late 2011 ... so long dated and i guess some punting that any sign of fda approval and jv partner would still see this climb to .05 etc ... therefore oppies offer a highly leveraged reward play. can they get some revenue in the door or get good coin for their saleable assets ... time!
- Forums
- ASX - By Stock
- set for a run
m, oppies ate .02 to pay in late 2011 ... so long dated and i...
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
30.5¢ | 32.0¢ | 30.5¢ | $551.7K | 1.772M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 204215 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 14929 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 210628 | 0.310 |
21 | 496484 | 0.305 |
8 | 155031 | 0.300 |
10 | 139668 | 0.295 |
8 | 152615 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 25460 | 9 |
0.320 | 165687 | 14 |
0.325 | 280126 | 10 |
0.330 | 65414 | 6 |
0.335 | 120295 | 9 |
Last trade - 15.01pm 13/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online